309 related articles for article (PubMed ID: 11526485)
21. Frequent loss of heterozygosity on chromosome 10q in muscle-invasive transitional cell carcinomas of the bladder.
Cappellen D; Gil Diez de Medina S; Chopin D; Thiery JP; Radvanyi F
Oncogene; 1997 Jun; 14(25):3059-66. PubMed ID: 9223669
[TBL] [Abstract][Full Text] [Related]
22. Evidence for two bladder cancer suppressor loci on human chromosome 9.
Ruppert JM; Tokino K; Sidransky D
Cancer Res; 1993 Nov; 53(21):5093-5. PubMed ID: 8221642
[TBL] [Abstract][Full Text] [Related]
23. Homozygous deletion at the 9q32-33 candidate tumor suppressor locus in primary human bladder cancer.
Nishiyama H; Takahashi T; Kakehi Y; Habuchi T; Knowles MA
Genes Chromosomes Cancer; 1999 Oct; 26(2):171-5. PubMed ID: 10469456
[TBL] [Abstract][Full Text] [Related]
24. [The diagnostic value of microsatellite LOH analysis and the prognostic relevance of angiogenic gene expression in urinary bladder cancer].
Szarvas T
Magy Onkol; 2009 Dec; 53(4):385-9. PubMed ID: 20071311
[TBL] [Abstract][Full Text] [Related]
25. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
Xu XF; Tang PZ; Cheng SJ
Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
[TBL] [Abstract][Full Text] [Related]
26. TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples.
Dahse R; Utting M; Werner W; Schimmel B; Claussen U; Junker K
Int J Oncol; 2002 Jan; 20(1):107-15. PubMed ID: 11743649
[TBL] [Abstract][Full Text] [Related]
27. Molecular alterations associated with bladder cancer initiation and progression.
Cordon-Cardo C
Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
[TBL] [Abstract][Full Text] [Related]
28. Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction.
Cairns P; Tokino K; Eby Y; Sidransky D
Cancer Res; 1994 Mar; 54(6):1422-4. PubMed ID: 8137242
[TBL] [Abstract][Full Text] [Related]
29. Genetic progression and heterogeneity associated with the development of esophageal squamous cell carcinoma.
Roth MJ; Hu N; Emmert-Buck MR; Wang QH; Dawsey SM; Li G; Guo WJ; Zhang YZ; Taylor PR
Cancer Res; 2001 May; 61(10):4098-104. PubMed ID: 11358832
[TBL] [Abstract][Full Text] [Related]
30. Identification of a 6-cM minimal deletion at 11q23.1-23.2 and exclusion of PPP2R1B gene as a deletion target in cervical cancer.
Pulido HA; Fakruddin MJ; Chatterjee A; Esplin ED; Beleño N; Martinez G; Posso H; Evans GA; Murty VV
Cancer Res; 2000 Dec; 60(23):6677-82. PubMed ID: 11118052
[TBL] [Abstract][Full Text] [Related]
31. Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer.
Zhuang Z; Merino MJ; Chuaqui R; Liotta LA; Emmert-Buck MR
Cancer Res; 1995 Feb; 55(3):467-71. PubMed ID: 7834608
[TBL] [Abstract][Full Text] [Related]
32. Cluster of allele losses within a 2.5 cM region of chromosome 10 in high-grade invasive bladder cancer.
Kagan J; Liu J; Stein JD; Wagner SS; Babkowski R; Grossman BH; Katz RL
Oncogene; 1998 Feb; 16(7):909-13. PubMed ID: 9484782
[TBL] [Abstract][Full Text] [Related]
33. Definition and refinement of chromosome 8p regions of loss of heterozygosity in gastric cancer.
Baffa R; Santoro R; Bullrich F; Mandes B; Ishii H; Croce CM
Clin Cancer Res; 2000 Apr; 6(4):1372-7. PubMed ID: 10778965
[TBL] [Abstract][Full Text] [Related]
34. Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors.
Orlow I; Lianes P; Lacombe L; Dalbagni G; Reuter VE; Cordon-Cardo C
Cancer Res; 1994 Jun; 54(11):2848-51. PubMed ID: 8187066
[TBL] [Abstract][Full Text] [Related]
35. Bladder cancer: allelic deletions at and around the retinoblastoma tumor suppressor gene in relation to stage and grade.
Wada T; Louhelainen J; Hemminki K; Adolfsson J; Wijkström H; Norming U; Borgström E; Hansson J; Sandstedt B; Steineck G
Clin Cancer Res; 2000 Feb; 6(2):610-5. PubMed ID: 10690546
[TBL] [Abstract][Full Text] [Related]
36. Role of chromosome 9 in human bladder cancer.
Miyao N; Tsai YC; Lerner SP; Olumi AF; Spruck CH; Gonzalez-Zulueta M; Nichols PW; Skinner DG; Jones PA
Cancer Res; 1993 Sep; 53(17):4066-70. PubMed ID: 8358736
[TBL] [Abstract][Full Text] [Related]
37. Deletion mapping implicates two tumor suppressor genes on chromosome 8p in the development of bladder cancer.
Takle LA; Knowles MA
Oncogene; 1996 Mar; 12(5):1083-7. PubMed ID: 8649800
[TBL] [Abstract][Full Text] [Related]
38. Preliminary mapping of the deleted region of chromosome 9 in bladder cancer.
Cairns P; Shaw ME; Knowles MA
Cancer Res; 1993 Mar; 53(6):1230-2. PubMed ID: 8443801
[TBL] [Abstract][Full Text] [Related]
39. The random development of LOH on chromosome 9q in superficial bladder cancers.
van Tilborg AA; de Vries A; de Bont M; Groenfeld LE; Zwarthoff EC
J Pathol; 2002 Nov; 198(3):352-8. PubMed ID: 12375268
[TBL] [Abstract][Full Text] [Related]
40. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]